InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,467.51
(
-0.36%
)
US TECH 100
19,302.80
(
-0.54%
)
Dow Jones
38,999.24
(
0.42%
)
Brent Oil
85.06
(
0.43%
)
Bitcoin
64,798.33
(
-0.24%
)
Post# of 345953
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

freethemice

Send PM Follow Ignore
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

freethemice

Re: sulaco post# 109076

Thursday, 01/24/2013 1:25:23 AM

Thursday, January 24, 2013 1:25:23 AM

Post# of 345953
Actually, bavituximab is quite different than Avastin. They are both monoclonal antibodies but their targets are
not the same, and their mechanisms of action are very different. They also have a much different side effect profile.
I would not say that bavituximab is a super-charged Avastin.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM

North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM

VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM

Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Start posting your company's news
Only $200 per official company press release!